While most available COVID-19 vaccines target the virus’ spike protein in order to activate the immune response, variants including Delta and Omicron have mutations that affect this protein, making them more difficult for antibodies to detect.
A method that could be used to develop vaccines that are effective against these variants and other ones in the future is augmenting vaccines with a piece of another viral protein that is less susceptible to mutations than the spike protein.
cnxps.cmd.push(function () { cnxps({ playerId: ’36af7c51-0caf-4741-9824-2c941fc6c17b’ }).render(‘4c4d856e0e6f4e3d808bbc1715e132f6’); });
if(window.location.pathname.indexOf(“/food-recipes/”) != -1){document.getElementsByClassName(“divConnatix”)[0].style.display =”none”;var script = document.createElement(‘script’); script.src=”https://player.anyclip.com/anyclip-widget/lre-widget/prod/v1/src/lre.js”; script.setAttribute(‘pubname’,’jpostcom’); script.setAttribute(‘widgetname’,’0011r00001lcD1i_12258′); document.getElementsByClassName(‘divAnyClip’)[0].appendChild(script);}else if(window.location.pathname.indexOf(“/jpost-tech/”)!=-1){ document.getElementsByClassName(“divConnatix”)[0].style.display =”none”; var script = document.createElement(‘script’); script.src=”https://static.vidazoo.com/basev/vwpt.js”; script.setAttribute(‘data-widget-id’,’616dd69d1b04080004ac2cc0′); document.getElementsByClassName(‘divVidazoo’)[0].appendChild(script); }else if(window.location.pathname.indexOf(“/israel-news/”) == -1 &&window.location.pathname.indexOf(“/breaking-news/”)==-1 ){ document.getElementsByClassName(“divConnatix”)[0].style.display =”none”; var script = document.createElement(‘script’); script.src=”https://static.vidazoo.com/basev/vwpt.js”; script.setAttribute(‘data-widget-id’,’60fd6becf6393400049e6535′); document.getElementsByClassName(‘divVidazoo’)[0].appendChild(script); }
Experts from the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at the University of California, Los Angeles (UCLA), found that a part of a protein present in SARS-CoV-2, viral polymerase, may fit the bill.
Viral polymerases, which appear in some coronaviruses, are used in viral replication. Whereas the spike protein may be affected by mutations as the virus spreads and subsequently evolves, viral polymerases are not likely to mutate.
To find whether or not humans have immune cell receptors that can detect viral polymerase, the UCLA team took blood samples from donors and introduced the polymerase antigen. They found that some receptors were able to detect the substance, so they sequenced these receptors and then augmented immune cells with them in order to observe how they could detect and destroy the virus.